blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2198055

EP2198055 - HUMANIZED PAI-1 ANTIBODIES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.08.2012
Database last updated on 15.07.2024
Most recent event   Tooltip24.08.2012Application deemed to be withdrawnpublished on 26.09.2012  [2012/39]
Applicant(s)For all designated states
Cisthera, Incorporated
6202 105th Avenue NE
Kirkland, WA 98033 / US
[2010/25]
Inventor(s)01 / STAUNTON, Donald, E.
6202 105th Avenue NE
Kirkland, WA 98033 / US
02 / VASQUEZ, Maximiliano
3813 Louis Road
Palo Alto, CA 94303 / US
 [2010/25]
Representative(s)Sahans, Sarah Anne, et al
Avidity IP
Kestrel House
Falconry Court
Baker's Lane
Epping, Essex CM16 5DQ / GB
[N/P]
Former [2010/25]Sahans, Sarah Anne, et al
HLBBshaw Merlin House Falconry Court Baker's Lane
Epping, Essex CM16 5DQ / GB
Application number, filing date08799269.905.09.2008
[2010/25]
WO2008US75489
Priority number, dateUS20070970871P07.09.2007         Original published format: US 970871 P
[2010/25]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009033095
Date:12.03.2009
Language:EN
[2009/11]
Type: A2 Application without search report 
No.:EP2198055
Date:23.06.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 12.03.2009 takes the place of the publication of the European patent application.
[2010/25]
Search report(s)International search report - published on:US04.06.2009
(Supplementary) European search report - dispatched on:EP19.03.2012
ClassificationIPC:C12Q1/68, C07K17/00, C07K14/00, C07K16/36
[2012/16]
CPC:
C07K16/36 (EP,US); A61P11/00 (EP); A61P31/00 (EP);
A61P9/00 (EP); C07K2317/24 (EP,US); C07K2317/56 (EP,US);
C07K2317/565 (EP,US); C07K2317/567 (EP,US); C07K2317/76 (EP,US) (-)
Former IPC [2010/25]C12Q1/68, C07K17/00, C07K14/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/25]
TitleGerman:HUMANISIERTE PAI-1-ANTIKÖRPER[2010/25]
English:HUMANIZED PAI-1 ANTIBODIES[2010/25]
French:ANTICORPS PAI-1 HUMANISÉS[2010/25]
Entry into regional phase07.04.2010National basic fee paid 
07.04.2010Search fee paid 
07.04.2010Designation fee(s) paid 
07.04.2010Examination fee paid 
Examination procedure07.04.2010Examination requested  [2010/25]
03.06.2010Amendment by applicant (claims and/or description)
03.04.2012Application deemed to be withdrawn, date of legal effect  [2012/39]
09.05.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/39]
Fees paidRenewal fee
27.09.2010Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.09.201104   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9501452  (AKZO NOBEL NV [NL], et al) [A] 1-15 * the whole document *;
 [A]US2003217371  (VAUGHAN DOUGLAS E [US], et al) [A] 1-15 * the whole document *
International search[A]US2001034327  (BRUNNER NIELS [DK], et al);
 [A]WO2006113909  (SEATTLE GENETICS INC [US], et al);
 [A]US2007048315  (PRESTA LEONARD G [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.